Novartis AG

NVSEF | OTC

Price Alert Chart Builder DCF Calculator

$138.25

+$4.55 (+3.40%)

At close: Sep 21, 2026, 3:47 PM ET

$138.25

$0 (0.00%)

After-hours: Sep 21, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020	FY 2019 Dec 30, 2019
Revenue	51.72B	46.66B	51.83B	52.88B	49.9B	48.68B
Cost of Revenue	12.83B	12.02B	15.49B	15.87B	15.12B	14.43B
Gross Profit	38.9B	34.64B	36.34B	37.01B	34.78B	34.25B
Operating Income	14.54B	9.77B	9.2B	11.69B	10.15B	9.09B
Interest Income	550.78M	436M	389.37M	71.15M	91M	251.43M
Pretax Income	13.64B	9.12B	8.37B	26.14B	9.88B	8.94B
Net Income	11.94B	14.85B	6.96B	24.02B	8.07B	11.73B
Selling & General & Admin	12.57B	12.49B	14.25B	14.89B	14.2B	14.37B
Research & Development	10.02B	11.37B	10B	9.54B	8.98B	9.4B
Other Expenses	1.76B	1.01B	-101.22M	269.57M	110.43M	305.83M
Operating Expenses	24.35B	24.87B	27.15B	25.32B	24.63B	25.17B
Interest Expense	1.01B	855M	860.33M	906.93M	869M	925.69M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	37.18B	36.89B	42.63B	41.19B	39.75B	39.59B
Income Tax Expense	1.7B	551M	1.42B	2.12B	1.81B	1.79B
Shares Outstanding (Basic)	2.02B	2.08B	2.18B	2.24B	2.28B	2.29B
Shares Outstanding (Diluted)	2.04B	2.09B	2.2B	2.26B	2.3B	2.32B
EPS (Basic)	5.92	7.63	3.29	10.73	3.76	3.15
EPS (Diluted)	5.87	7.58	3.27	10.65	3.73	3.12
EBITDA	20.72B	19.52B	15.21B	17.17B	16.18B	15.62B
EBIT	14.65B	10.68B	8.28B	11.73B	10.15B	9.09B
Depreciation & Amortization	6.07B	8.83B	6.92B	5.44B	5.43B	5.98B